Sensipar Tablet, Coated
Product Images NDC 55513-073

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Sensipar (NDC 55513-073). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amgen Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Sensipar 01)

Chemical structure of cinacalcet hydrochloride, the active ingredient in Sensipar tablets. The diagram shows the molecular structure including a trifluoromethyl group, aromatic rings, and the HCl component.*

FDA Label Image

Figure 1. Mean (se) Ipth Values (pooled Phase 3 Studies) (Sensipar 02)

A line graph comparing parathyroid hormone (PTH) levels (pg/mL) over a 26-week period between patients treated with Sensipar and a placebo group. The graph shows PTH levels decreasing steadily in the Sensipar group, while remaining relatively stable in the placebo group.*

FDA Label Image

Figure 2. Mean (se) Ca X P Values (pooled Phase 3 Studies) (Sensipar 03)

A line graph comparing calcium-phosphorus product (Ca x P) levels (mg/dL) over 26 weeks between Sensipar treated group and placebo group. The Sensipar group shows a decrease and stabilization of Ca x P levels, while the placebo group remains relatively constant. Error bars represent variability at each time point.*

FDA Label Image

Figure 3. Serum Calcium Values In Patients With Parathyroid Carcinoma Receiving Sensipar At Baseline, Titration, And Maintenance Phase (Sensipar 04)

A line graph showing serum calcium levels (mg/dL) over time in weeks for patients with parathyroid carcinoma. The x-axis represents weeks from baseline to 80 weeks, divided into titration and maintenance phases. The y-axis measures calcium levels ranging from 8 to 16 mg/dL. Data points include error bars, indicating variability or confidence intervals for each time point.*

FDA Label Image

Figure 4. Mean Serum Calcium (se) At Baseline, End Of Titration, And Scheduled Maintenance Visits (patients With Severe Intractable Primary Hpt) (Sensipar 05)

A line graph showing calcium levels (mg/dL) over time in weeks during titration and maintenance phases. The x-axis represents weeks (baseline through 80 weeks), and the y-axis represents calcium levels ranging from 8 to 16 mg/dL. Data points with error bars depict changes in calcium concentration with a noticeable drop after baseline and stabilization around 10 mg/dL during maintenance.*

FDA Label Image

Principal Display Panelamgen®ndc 55513-073-30sensipar®(cinacalcet ) Tabletsrx Only 30 Tablets30 mgeach Tablet Contains :cinacalcet 30 mg (equivalent To 33 mg Of Cinacalcet Hydrochloride).store At 25°c (77°f); Excursions Permitted To 15-30°c (59-86°f).see Usp Controlled Room Temperature.dispense In Tight, Light-resistant Container Per Usp.dosage : See Package Insert.© 2004-2018 Amgen Inc. All Rights Reserved.patent : Http://pat.amgen.com/sensipar/distributed By : Amgen,one Amgen Center Drive,thousand Oaks, Ca 91320-1799made In Japan (Sensipar 07)

Sensipar 30 mg tablets packaging label by Amgen Inc. The label shows the proprietary name Sensipar with the generic name cinacalcet below. It indicates an oral coated tablet dosage form, with 30 tablets in the package. The label includes storage instructions and specifies the dosage strength as 30 mg of cinacalcet.*

FDA Label Image

Principal Display Panelamgen®ndc 55513-074-30sensipar®(cinacalcet ) Tabletsrx Only 30 Tablets60 mgeach Tablet Contains :cinacalcet 60 mg (equivalent To 66 mg Of Cinacalcet Hydrochloride).store At 25°c (77°f); Excursions Permitted To 15-30°c (59-86°f).see Usp Controlled Room Temperature.dispense In Tight, Light-resistant Container Per Usp.dosage : See Package Insert.© 2004-2018 Amgen Inc. All Rights Reserved.patent : Http://pat.amgen.com/sensipar/distributed By : Amgen,one Amgen Center Drive,thousand Oaks, Ca 91320-1799made In Japan (Sensipar 08)

Sensipar 60 mg coated oral tablets packaging label by Amgen Inc. The label indicates 30 tablets per container. Each tablet contains cinacalcet 60 mg (equivalent to 66 mg cinacalcet hydrochloride). Storage instructions specify 25°C with permitted excursions. Regulatory details like NDC 55513-074-30 are visible along with dosage reference to the package insert.*

FDA Label Image

Principal Display Panelamgen®ndc 55513-075-30sensipar®(cinacalcet ) Tabletsrx Only 30 Tablets90 mgeach Tablet Contains :cinacalcet 90 mg (equivalent To 99 mg Of Cinacalcet Hydrochloride).store At 25°c (77°f); Excursions Permitted To 15-30°c (59-86°f).see Usp Controlled Room Temperature.dispense In Tight, Light-resistant Container Per Usp.dosage : See Package Insert.© 2004-2018 Amgen Inc. All Rights Reserved.patent : Http://pat.amgen.com/sensipar/distributed By : Amgen,one Amgen Center Drive,thousand Oaks, Ca 91320-1799made In Japan (Sensipar 09)

Sensipar 90 mg coated tablets label by Amgen Inc. The label shows the proprietary name Sensipar with the generic name cinacalcet. The package contains 30 tablets. The label includes storage instructions and dosage strength of 90 mg (equivalent to 99 mg cinacalcet hydrochloride). The label also displays the NDC number 55513-075-30 and distributor information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.